Floatz logo

Sc-Car.Gpc3Xil15.21 Car T Cells

Solid Tumor (Excluding CNS)

Seattle Children's HospitalCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Solid Tumor (Excluding CNS) cohort.

Asset / SponsorPhaseRating
Pixantrone
CTI BioPharma
Phase 1CC

Same molecule, other indications

Sc-Car.Gpc3Xil15.21 Car T Cells is also rated in:

liposarcomaDormant
CC
Indicative ·
43 / 100
View asset →
yolk sac tumorDormant
CC
Indicative ·
43 / 100
View asset →
rhabdoid tumorDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →